USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Biopep Solutions, Inc.

USPTO PatentsView assignee record - 13 granted patents across 4 technology areas, recorded in grant years 2015–2018. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

RSS updates for this company

The verdict

According to USPTO PatentsView, Biopep ranks #20,836 of 49,997 tracked US assignees by granted-patent volume, with 13 patents across 4 technology areas.

#20,836
of 49,997 US assignees by volume
25th percentile
by Innovation Score (27.9/100)
19.5
avg claims per patent
-100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R20836 · Foreign Corporation #20,836 · 13 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

  • GRANTS-MICRO 13 grants
  • MID-PACK #20,836/49,997
  • PHOTO-FINISH BioEnergenix
  • CPC-NARROW A61P · 4 areas
  • INNOV-THIN 27.9/100
  • CLAIMS-RICH 19.5 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-DROP -100% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: BioEnergenix LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Biopep’s 27.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Biopep

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Biopep's Innovation Score is 27.9/100 (25th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Biopep?

Each dot is one of Biopep’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Biopep’s own 19.5 claims/patent is ABOVE the 17.7 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Biopep vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 12.912.91313.1 010203040 Granted patents (volume) Avg claims / patent BioEnergenix LLC - 13, 6.46BioenergenixBioLife Solutions, Inc. - 13, 25.92Biolife SolutionsBiomason Inc. - 13, 23.85BiomasonBiomatrica, Inc. - 13, 15.08BiomatricaBiorez, Inc. - 13, 17.69BiorezBlack Hills Media, LLC - 13, 29.85Black Hills MediaBlack Mountain Industries, Inc. - 13, 18.54Black Mountain In…Blackhawk Specialty Tools, LLC - 13, 12.46Blackhawk Special…Biopep Solutions, Inc. - 13, 19.46Biopep Solutions
Biopep vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Biopep's grants concentrate

Biopep Solutions, Inc. is a focused PatentsView assignee: 4 CPC subclasses with 100% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2015 (6 grants) versus a trough of 1 in 2017. By volume, Biopep sits between BioEnergenix LLC and Blackhawk Specialty Tools, LLC.

Who files at Biopep's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Biopep holds 13 patents at rank #20,855, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Biopep

By rank, the assignees closest to #20,855 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Biopep's primary technology class.

Biopep's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

28 25th percentile higher than 25% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

02468 2015201620172018 1
USPTO utility patent grants by year · 2015–2018

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Biopep Solutions, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 6 46.2%
2016 5 38.5%
2017 1 7.7%
2018 1 7.7%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Biopep Solutions, Inc.'s patent record in context - here's where to go next.

  • Biopep Solutions, Inc.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 100% of its portfolio - see every assignee active in that class. Explore A61P
  • Ranked #20,836 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Biopep Solutions, Inc. against BioEnergenix LLC, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 27.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.